Macquarimicin A inhibits membrane-bound neutral sphingomyelinase from rat brain

Journal of Antibiotics

Volumn 52, Issue 7, 1999, Pages 670-673

  Tanaka, Masahiro ^a   Nara, Futoshi ^a   Yamasato, Yoko ^a   Masuda Inoue, Seiko ^a   Doi Yoshioka, Hiromi ^a   Kumakura, Seiichiro ^a   Enokita, Ryuzo ^a   Ogita, Takeshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIAL ENZYME; BRAIN ENZYME; CARRAGEENAN; CERAMIDE; DEXAMETHASONE; ENZYME INHIBITOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIVER ENZYME; MACQUARIMICIN A; PROSTAGLANDIN E2; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG POTENCY; DRUG SPECIFICITY; DRUG STRUCTURE; FERMENTATION; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT;

EID: 0032813158     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.670     Document Type: Article

References (19)

1. BALLOU, L. R.; S. J. F. LAULEDERKIND, E. F. ROSLONIEC & R. RAGHOW: Ceramide signalling and the immune response. Biochim. Biophys. Acta 1301: 273-287, 1996
2. KOLESNICK, R. & D. W. GOLDE: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994
3. OBEID, L. M & Y. A. HANNUN: Ceramide: A stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 58: 191-198, 1995
4. HANNUN, Y. A.: Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859, 1996
5. CANDELA, M.; S. C. BARKER & L. R. BALLOU: Sphingosine synergistically stimulates tumor necrosis factor alpha-induced prostaglandin E2 production in human fibroblasts. J. Exp. Med. 174: 1363-1369, 1991
6. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem. 267: 20044-20050, 1992
7. MATHIAS, S.; A. YOUNES, C. C. KAN, I. ORLOW, C. JOSEPH & R. N. KOLESNICK: Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259: 519-522, 1993
8. DBAIBO, G. S.; L. M. OBEID & Y. A. HANNUN: Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J. Biol. Chem. 268: 17762-17766, 1993
9. LAULEDERKIND, S. J. F.; A. BIELAWSKA, R. RAGHOW, Y. A. HANNUN & L. R. BALLOU: Ceramide induces interleukin 6 gene expression in human fibroblasts. J. Exp. Med. 182: 599-604, 1995
10. TANAKA, M.; F. NARA, K. SUZUKI-KONAGAI, T. HOSOYA & T. OGITA: Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase. J. Am. Chem. Soc. 119: 7871-7872, 1997
11. NARA, F.; M. TANAKA, T. HOSOYA, K. SUZUKI-KONAGAI & T. OGITA: Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: Taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties. J. Antibiotics 1999 submitted
12. NARA, F.; M. TANAKA, S. MASUDA-INOUE, Y. YAMASATO, H. DOI-YOSHIOKA, K. SUZUKI-KONAGAI, S. KUMAKURA & T. OGITA: Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J. Antibiotics 1999 submitted
13. TANAKA, M.; F. NARA, Y. YAMASATO, Y. ONO & T. OGITA: F-11334s, new inhibitors of membrane-bound neutral sphingomyelinase. J. Antibiotics 1999 submitted
14. JACKSON, M.; J. P. KARWOWSKI, R. J. THERIAULT, R. R. RASMUSSEN, D. M. HENSEY, P. E. HUMPHREY, S. J. SWANSON, G. J. BARLOW, U. PREMACHANDRAN & J. B. MCALPINE: Macquarimicins, microbial metabolites from micromonospora. I. Discovery, taxonomy, fermentation and biological properties. J. Antibiotics 48: 462-466, 1995
15. HOCHLOWSKI, J. E.; M. M. MULLALLY, R. HENRY, D. M. WHITTERN & J. B. MCALPINE: Macquarimicins, microbial metabolites from micromonospora. II. Isolation and structural elucidation. J. Antibiotics 48: 467-470, 1995
16. LISTER, M. D.; C. L. CRAWFORD-REDICK & C. R. LOOMIS: Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3. Biochim. Biophys. Acta 1165: 314-320, 1993
17. HAIMOVITZ-FRIEDMAN, A.; C. CORDON-CARDO, S. BAYOUMY, M. GARZOTTO, M. MCLOUGHLIN, R. GALLILY, C. K. EDWARDS III, E. H. SCHUCHMAN, Z. FUKS & R. KOLESNICK: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186: 1831-1841, 1997
18. PFAU, J. C.; E. B. WALKER & G. L. CARD: A comparison of the effects of lipopolysaccharide and ceramide on arachidonic acid metabolism in THP-1 monocytic cells. Cellular Immunology 186: 147-153, 1998
19. PAHAN, K.; F. G. SHEIKH, M. KHAN, A. M. S. NAMBOODIRI & I. SINGH: Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273: 2591-2600, 1998